Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and pharmacokinetics/dynamics of DS-1040b in subjects with acute submassive pulmonary embolism has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Thrombotic Disease

Drugs mentioned

• DS-1040b (DS-1040b)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Pulmonary Embolism, Thrombotic Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-30